Results 201 to 210 of about 34,166 (308)

Early onset of diabetic nephropathy [PDF]

, 1997
Jane M Francis, Susan J. Rose, F. Raafat, David V. Milford   +3 more
openalex   +1 more source

Efficacy and safety of iGlarLixi versus IDegAsp by baseline β‐cell function in Chinese people with type 2 diabetes: Exploratory analyses of the Soli‐D study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To compare the efficacy and safety of insulin glargine 100 U/mL plus lixisenatide (iGlarLixi) with insulin degludec plus insulin aspart (IDegAsp) by β‐cell function in exploratory analyses of the Soli‐D study. Materials and Methods Soli‐D was a 24‐week, multicentre, randomised, open‐label study in Chinese adults with uncontrolled type 2 ...
Weijun Gu, Xiaohong Wu, Minlu Zhang, Xinyi Wang, Qin Du, Lei Kang, Felipe Lauand, Agustina Alvarez, Yiming Mu   +8 more
wiley   +1 more source

Incidence and predictors of diabetic kidney disease among type 2 diabetes mellitus adult patients in Ethiopia: a systematic review and meta-analysis. [PDF]

BMC Endocr Disord
Wudu MA, Birhanu TA, Tegegne KD, Wondifraw EB.   +3 more
europepmc   +1 more source

A polymorphism in the gene for the atrial natriuretic peptide and diabetic nephropathy [PDF]

, 1998
Susanne Schmidt, Martin Blüthner, R Giessel, K Strojek, K. Bergis, W Grzeszczak, Eberhard Ritz   +6 more
openalex   +1 more source

Cdk5 Contributes to Diabetic Islet β Cell and Kidney Injury by Impairing Autophagy. [PDF]

FASEB J
Tao Y, Wang L, Liu Y, Wei Y, Wang R, Sha S, Zheng S, Hou S, Liu S.   +8 more
europepmc   +1 more source

Clinicopathological Study of Diabetic Nephropathy in the Elderly.

, 1996
Masao Kanauchi, Hideo Shiiki, Yuichi Fujii, K Dohi   +3 more
openalex   +2 more sources

Serum Visfatin Level and Cardiac Valve Calcifcation in Hemodialysis Patients

Hemodialysis International, EarlyView.
ABSTRACT Background Cardiac valve calcification is a serious complication in patients with cardiovascular disease. This study investigated the relationship between visfatin levels and cardiac valve calcification in individuals undergoing hemodialysis.
Xiaoqi Wang, Dan Yuan, Feng Shao, Conghui Liu, Xiao Zhang, Zhongxin Li   +5 more
wiley   +1 more source

Dysregulation of miR-302a-3p in diabetic nephropathy and its role in inflammatory response. [PDF]

BMC Endocr Disord
Lv L, Zhang X, Luo G.
europepmc   +1 more source

Cellular events in the evolution of experimental diabetic nephropathy

, 1995
Bessie A. Young, Richard J. Johnson, Charles E. Alpers, Eudora Eng, Katherine Gordon, Jürgen Floege, William G. Couser, W. Seidel   +7 more
openalex   +1 more source

Practical Use of Continuous Glucose Monitoring to Adjust Glucose‐Lowering Therapy in Hemodialysis Patients: A Case Series

Hemodialysis International, EarlyView.
ABSTRACT Introduction Diabetes management in hemodialysis patients is complicated by limited treatment options and challenges in glycemic monitoring. Continuous glucose monitoring (CGM) provides detailed glucose profiles, enabling tailored glucose‐lowering therapy.
Christine L. Meyer‐Olesen, Merete B. Christensen, Dea H. Kofod, Mads Hornum, Kirsten Nørgaard, Tobias Bomholt   +5 more
wiley   +1 more source